Featured Report:

Lifetime Trends in Biopharmaceutical Innovation

This report profiles the new active substances (NASs) launched in the U.S. over the past 20 years and measures the length of a molecule’s lifetime from patent filing to launch and eventual patent expiry. It also explores the significant variations in this lifetime when viewed by molecule characteristics such as therapy area, orphan drug status, and the type of companies involved in the development and marketing.

Read More   See All Reports

A Global Presence

The QuintilesIMS Institute, in various regions, is developing partnerships with institutions and individuals to reinforce the value of information and analytics in decision making across a range of healthcare issues in this extensive, complex and rapidly developing market. Learn more about our efforts in the following locations:

Learn How the QuintilesIMS Institute Brings Unique Perspectives to the Healthcare Industry

To learn more about ways that the QuintilesIMS Institute can support your initiatives, please reach out to our team: